315
Views
14
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Determination of precipitation inhibitory potential of polymers from amorphous solid dispersions

, &
Pages 1933-1941 | Received 07 May 2018, Accepted 17 Jul 2018, Published online: 11 Sep 2018
 

Abstract

Precipitation inhibitory potential of polymers screened from precipitation study may be altered once it is formulated in amorphous solid dispersions (ASDs).

Objective: Present study was embarked with an objective to determine whether the polymers retain the same inhibitory potential after formulating them into ASDs.

Methods: Screening of polymers was based on a new dimensionless parameter ‘Supersaturation Holding Capacity (SHC)’ calculated from the precipitation study. Nifedipine ASDs were formulated using HPMC E3 and HPMC E50 (high SHC values), and HPMC K100M, PVP K25, and HPC M (low to moderate SHC values). Generated ASDs were characterized by DSC, FTIR, and PXRD and evaluated for stability under accelerated conditions (40˚C and 75% RH) for 6 months.

Results: Thermal analysis of the ASDs and theoretical prediction of the glass transition temperature (Tg) suggested a linear dependency of Tg on the content of HPMC E3 and HPMC E50. Under accelerated stability conditions, all ASDs of nifedipine with HPMC E3 and HPMC E50 (except ASDs with 70% drug load) were stable, which could be attributed to the molecular level dispersion of the drug in these polymers. SHC parameter calculated from the apparent solubility profile gave following rank order HPMC E50 (3.4) > HPMC E3 (3.2) > HPMC K100M (1.29) > PVP K25 (1.09) > HPC M (0.99). SHC calculated from the apparent solubility profile of ASDs demonstrated good agreement between the solution state and solid state screening of the polymers for precipitation inhibition. During dissolution study, nearly four-fold enhancement has been observed with ASDs comprising HPMC E3 and HPMC E50.

Conclusions: The outcome of the study concluded that SHC can be a promising parameter in the screening of polymers for the development of the ASDs.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was financially supported by the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, Govt. of India.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.